S100B and HIV-1 infection: To examine whether the use of 1% tenofovir microbicide gel selected for transmitted/early HIV-1 strains with enhanced fitness, we assessed the sequence and in vitro function of plasma RNA-derived gag-protease and nef genes from the majority of incident HIV-1 infections in the CAPRISA 004 trial.